View Single Post
  #55  
Old 06-07-2019, 08:51 PM
Nunzio11's Avatar
Nunzio11 Nunzio11 is offline
Tony
Member
 
Join Date: Oct 2016
Location: Maryland
Posts: 233
Default

Quote:
Originally Posted by joshuanip View Post
From an accounting perspective, there is nothing needed to be disclosed, yet.

Deemed contingent liability, it needs to be recorded and disclosed if the liability meets more than likelihood possibility. Although there there may be an inquiry, if there is not yet direct investigation yet of PSA's subsidiary, it is still in discovery and too early to determine liklihood; allowing the company to take the generic "ordinary course" liability disclosure in its notes. Auditors and SEC would sign off as long as there is not enough information to determine the extent of the liability.

Would like to see the Q&A transcript for the Q if they have earnings calls. Is there any brokers that cover them?
The company is not covered by any major (or minor) sell side research firms. It’s just too small, illiquid and tightly held for an investment bank to research. The only company that covers it research wise is a general IR firm. Seeking Alpha will help get the word out but larger Wall Street firms typically take their view with a grain of salt.
Reply With Quote